Status:
COMPLETED
Renal Transplant Injury and the Renin-Angiotensin System in Kids (RETASK)
Lead Sponsor:
Wake Forest University Health Sciences
Collaborating Sponsors:
Stanford University
Conditions:
Renal Transplant
Renin-Angiotensin System
Eligibility:
All Genders
1-20 years
Brief Summary
In pediatric kidney transplant patients, rejection, medication toxicity and ischemia cause early and chronic renal allograft injury, which reduces graft lifespan and patient survival. Early detection ...
Detailed Description
Kidney damage activates the traditional renin-angiotensin (Ang) system (RAS), characterized by Ang-converting enzyme (ACE)/Ang II/Ang II type 1 receptor. The Ang-converting enzyme 2 (ACE2)/Ang-(1-7)/M...
Eligibility Criteria
Inclusion
- Ages 1 - 20 years
- Actively listed on the transplant list at Lucile Packard Children's Hospital at Stanford and received a renal transplant during the study enrollment period
Exclusion
- Transplanted at a center other than Lucile Packard Children's Hospital at Stanford
Key Trial Info
Start Date :
July 16 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 26 2017
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT03317925
Start Date
July 16 2014
End Date
April 26 2017
Last Update
November 8 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wake Forest University Baptist Medical Center
Winston-Salem, North Carolina, United States, 27157